Skip to main content
Premium Trial:

Request an Annual Quote

HP, Partners HealthCare Extend Personalized Medicine Collaboration

NEW YORK (GenomeWeb News) – Hewlett Packard and Partners HealthCare have extended an ongoing agreement to develop software and implement hardware and services supporting Partners' personalized medicine and clinical genomics program, HP said today.

Under the five-year, "multi-million dollar" agreement, HP will extend Partners' IT infrastructure, with a particular focus on data storage capabilities to handle data from next-generation sequencing programs. The increase in genetic and genomic data output from new sequencing technologies requires a "cost-effective, high-performance computing storage environment," HP said.

The collaboration so far has benefited the Partners HealthCare Center for Personalized Medicine (PCPGM) by creating a large mini-cluster computer facility to support Partners' genetics researchers.

That infrastructure allowed PCPGM and HP to collaborate on the creation of the Gateway for Integrated Genomics-Proteomics Application and Data, which integrates disparate lab systems, provides a portal to submit and access bio-samples, and helps in managing workflows and data repositories.

The software solution developed at PCPGM is a component of the HP Digital Discovery and Development Solution, a collaborative architecture that enables translational research for life sciences companies.

"We believe the vision of personalized medicine, where clinicians are able to make diagnostic, treatment and clinical management decisions based on a patient's genetic profile, can only be realized by leveraging IT infrastructure that can keep pace with the fast rate of change in the genomics field," Partners Chief Information Officer John Glaser said in a statement.

Partners HealthCare is an integrated health system that was founded by Brigham and Women's Hospital and Massachusetts General Hospital.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.